PRISM Stock IndexesCurrent Value% Change (Daily)% Change (Inception)Most ActiveTop % GainersTop % Losers
AdTech and Media$88.60-2.7%-11.4%SIRI 39,127 GTN  2.17%DRCT -12.551%
Biotech$200.80-0.9%100.8%VXRT 4,186 AIM  5.475%NRSN -10.336%
Cannabis$115.50-1.4%15.5%TLRY 21,966 TCNNF  1.859%CARA -7.838%
Consumer Products$82.90-0.7%-17.1%PTON 16,886 NAII  4.618%NUZE -8.725%
EV$140.60-4.7%40.6%RIVN 45,931 GTEC  1.366%IDEX -12.799%
Global Health$95.60-2.9%-4.4%LGVN 9,598 LGVN  10.796%GOSS -12.8%
Healthcare$83.60-0.5%-16.4%HIMS 10,655 HCTI  7.121%BFRG -11.258%
NextGen Tech & AI$95.60-1.9%-4.4%SOUN 27,170 LPSN  10.343%BNAI -11.699%
New Energy$80.70-4.4%-19.3%MAXN 51,615 SPRU  1.539%LTBR -10.732%
MedDevices$100.10-0.7%0.1%AEMD 4,766 PAVM  11.058%NMTC -7.645%
Mental Health$88.200.7%-11.8%TALK 1,516 ABVC  16.381%NRXP -5.556%
Oil & Gas$97.500.7%-2.5%SWN 13,922 KLXE  10.669%EP -3.387%
Pharmaceuticals$110.30-0.6%10.3%BDRX 5,040 ARMP  10.738%CADL -9.877%
Psychedelics$90.70-2.7%-9.3%CYBN 4,230 HUGE  2.635%PBM -11.349%
Women’s Health$152.80-2.8%52.8%VSTM 890 SERA  3.906%AWH -15.758%
Zombie$107.50-3%7.5%AMC 60,772 FIVN  2.103%SNAP -9.727%

Prism View

Fields of Promise? KLX Energy (KLXE) Leads PRISM Oil and Gas Index Today, Here’s Why

Today the PRISM Oil and Gas Index company KLX Energy (KLXE) provided preliminary Q2 financial results that showed promise to investors as the stock traded up ~11% on the day. The company’s prior quarter steeply disappointed estimates on almost all…

An Inside Look: Veritone (VERI) Provides Q2 2024 Analysis on U.S. Bureau of Labor Statistics Jobs Data and AI Job Growth

The PRISM AdTech and Media Index company Veritone (VERI) who is a leader in in building human-centered enterprise AI solutions released an analysis on the Q2 2024 aggregated US Bureau of Labor Statistics (BLS) Jobs Reports, providing insights into the…

Stocks making the biggest moves premarket: Nvidia, GitLab, Five Below, J.B. Hunt and more

Take a closer look at these market movers prior to the bell. Semiconductor stocks are experiencing a dip as a Bloomberg report suggested the Biden Administration is considering tighter trade restrictions, raising fears that U.S. firms may be sharing too…

More June Suprises in Economic Reports: Retail Sales Better Than Expected

As Wall Street had predicted a 0.2% decline in June retail sales, today’s report surprised estimates…

PRISM EV Index Leader Greenland Technologies (GTEC) Announces Partnership With One of World’s Largest Construction Machinery Manufacturers

Current PRISM Emerging EV Index leader, Greenland Technologies (GTEC) is a developer and manufacturer of electric…

Stocks making the biggest moves premarket: Morgan Stanley, UnitedHealth, Bank of America and more

Here are the leading corporations making waves prior to market opening. Morgan Stanley — Despite strong…

C3 AI (AI) is Providing Answers to Government Questions with New AI Platform for Government Services

For those interested in getting their government related questions answered, the AI software application company C3…

Stocks making the biggest moves premarket: Trump Media & Technology, Apple, Super Micro Computer and more

Catch up on the latest corporate buzz before the markets open. Trump Media & Technology's shares…

Big Banks Talk Bucks as Q2 Earnings Season Kicks Off

This week’s earning season kicked off with the first round of Q2 results from the banking…

Feature Story

The Vital Role of Fresh Water in Data Centers

Data centers are the backbone of our digital world, supporting everything from social media to cloud storage. However, a lesser-known fact is their significant demand for fresh water. As data centers continue to proliferate, especially with the rise of AI, understanding their water usage and the implications on local water supplies is important. This article delves into why fresh water is essential for data centers, the scale of this demand, its impact, and what companies are doing to help fix this issue.


Q&A Corner

Ellen Kim

Soligenix’s HyBryte™: Lighting the Way Towards Commercial Success with Promising FLASH Study Results

Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin’s lymphoma with no FDA-approved first-line treatments on the market. Approximately 3,000 new CTCL cases are diagnosed in the United States each year and more than 20,000 patients are living with CTCL. Late-Stage biotech company Soligenix (Nasdaq: SNGX) is developing and moving toward potential commercialization of HyBryte™ (synthetic hypericin) as a novel first-in-class photodynamic therapy that uses safe visible light for the treatment of early-stage CTCL.

Ellen Kim, MD, Director, Penn Cutaneous Lymphoma Program, Vice Chair of Clinical Operations, Dermatology Department, and Professor of Dermatology at the Hospital of the University of Pennsylvania was the Lead Principal Investigator for Soligenix’s Phase 3 FLASH (Fluorescent Light Activated Synthetic Hypericin) study in CTCL.

On July 9th, Dr. Kim publicly disclosed interim results from an ongoing open-label, investigator-initiated study (IIS) she sponsored evaluating extended HyBryte™ treatment for up to 12 months in patients with early-stage CTCL. This study is currently being supported by a $2.6 million Orphan Products Development Grant awarded by the U.S. Food and Drug Administration (FDA).

We had the chance to sit down with her to discuss the positive preliminary findings as well as what’s next for this potentially breakthrough treatment.

Traders Lens

4D Molecular Therapeutics Inc.

Biotech company $FDMT has faded pretty hard after starting the day up. The stock is currently down upwards of 30%. Earlier today the company released results from their PRISM Phase 2 Clinical Trial, which they described as positive, but clearly it wasn’t quite what the market was looking for.

AngioDynamics Inc.

$ANGO is leading the Prism MarketView MedDevices index after posting Q4 earnings this morning.

Upstart Holdings Inc.

AI lending company $UPST is up about 10% right now and looks to be testing a resistance point at about $30, where it gapped below in mid-February

Bio View

Immuron Reports Record US and Australian Sales of Travelan

Australian biotechnology company, Immuron Limited (Nasdaq: IMRN), has achieved record sales of its over-the-counter immune supplement, Travelan®, an orally administered immunotherapy that reduces the likelihood of contracting Travelers’ Diarrhea, a digestive tract disorder that is commonly caused by pathogenic bacteria…

Clearmind Medicine Surges on Psychoactive Agent’s Impact on Obesity and Binge Behavior

Shares in psychedelic-derived therapeutics company, Clearmind Medicine (Nasdaq: CMND), surged on Monday after the company announced it will participate in the 2024 Psychedelic Medicine – Israel conference. The annual event brings together leading experts and researchers from around the world…

Sera Prognostics Rises on Positive Topline Results from Preterm Birth Treatment Study

The Pregnancy Company®, Sera Prognostics (Nasdaq: SERA), has  announced that positive data from its  AVERT PRETERM TRIAL has been published in the international, peer-reviewed journal, Diagnostics. Sera rose to the top of the PRISM Emerging Women’s Health Index following the…

Vistagen Tops PRISM Mental Health Index with Migraine Patent News

Neuroscience-focused biopharmaceutical company, Vistagen Therapeutics (Nasdaq: VTGN), topped the PRISM Mental Health Index on Thursday, rising…

A New Vision for Treating Eye Pain: OKYO Pharma Initiates Phase 2 Trial of OK-101 for Neuropathic Corneal Pain

OKYO Pharma Limited (NASDAQ: OKYO), a leader in the development of novel ophthalmic therapies, saw its…

Oncocyte CEO Josh Riggs on Market Disruption, Product Market Fit and Future Outlook Featured on MedTech Guru’s Podcast

CEO Josh Riggs of the molecular diagnostics technology company, Oncocyte (OCX) was featured on the MedTech…

BioStem (BSEM) Obtains Institutional Review Board (IRB) Approval to Advance Clinical Study Utilizing AmnioWrap2™ to Treat Diabetic Foot Ulcers

A leader in regenerative medicine, BioStem Technologies (BSEM) announced the IRB has approved a clinical study…
PRISM Indexes

Alaska Air third-quarter profit view lags estimates on hit from cabin crew deal

(Reuters) – Alaska Air (NYSE:ALK) Group forecast third-quarter profit below estimates on Wednesday, citing a financial hit from its new flight attendant contract deal, while… [Read More]